Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Niacin and Antipsychotic Agents

Research Papers that Mention the Interaction

It is important to consider the interactions between nicotinic and antipsychotic drugs to develop the most efficacious treatment for cognitive improvement in people with schizophrenia.
Nicotinic interactions with antipsychotic drugs , are complex since both nicotine and antipsychotics have complex actions.
Thus, it is critical to understand the interaction between nicotinic treatments and antipsychotic drugs.
Thus, nicotinic interactions with antipsychotic drugs are widespread.
Biochemical pharmacology  •  2007  |  View Paper
Serotonergic actions of antipsychotic drugs may decrease efficacy of nicotinic co-treatments.
Thus it appears that antipsychotic drugs with actions blocking 5HT2 receptors may limit the efficacy of nicotinic co-treatments for cognitive enhancement.
EXS  •  2006  |  View Paper
However, in schizophrenia the efficacy of nicotinic treatments may be limited by co-treatment with antipsychotic drugs like clozapine.
The international journal of neuropsychopharmacology  •  2008  |  View Paper
Given that many antipsychotic drugs have substantial 5-HT2 antagonist effects, these atypical antipsychotic drugs may reduce the cognitive improvements caused by nicotinic treatments.
Pharmacology Biochemistry and Behavior  •  2005  |  View Paper
Altogether, these results raise the possibility that atypical neuroleptics could derive some of their therapeutic effects not only from their well-known inhibitory action on dopaminergic receptors, but also from their pre- and post-synaptic modulation of nicotinic neurotransmission.
Neuropharmacology  •  2002  |  View Paper